Opinion: The real crime of Theranos: Loss of trust in real-time diagnostics
Ramesh Balwani, the chief operating officer of Theranos, was sentenced on Wednesday to nearly 13…
Author: STAT
Opinion: If you think health care is dysfunctional now, just wait until after January 1
Doctors across the country, especially those in primary care, have been up in arms about…
STAT+: Congress has a chance to close the FDA’s Theranos loophole
WASHINGTON – Theranos, and the company’s notoriously inaccurate blood tests, could potentially have been stopped…
Cancer patients endure an overlooked financial burden: hospital parking fees
For many patients, one of the most antagonizing parts of a hospital visit is paying…
STAT+: In ‘landmark’ study, cell therapy exceeds expectations in melanoma patients
When tumors like melanoma form, the immune system mobilizes for war. White blood cells called…
STAT+: ARPA-H’s new director wants to go on a hiring spree
President Biden’s new health agency with a sweeping mandate to cure some of the system’s…
‘I question what I know’: Top cancer specialist Otis Brawley on valuing orthodoxy in medicine
Oncologist Otis Brawley has dedicated his career to advocating for orthodoxy in medicine. Now, he…
STAT+: Could Vertex’s cystic fibrosis medicines hold a clue to treating deadly pneumonia?
About a year ago, a grad student came running up to Wolfgang Kuebler, looking all…
STAT+: FDA scolds company that raised red flags over impurities in many widely used medicines
Two years after an independent laboratory began pushing the U.S. Food and Drug Administration to…
STAT+: FDA chief calls agency’s food program ‘under-supported, under-resourced’
FDA Commissioner Robert Califf said the food side of the agency needs more attention Wednesday,…
STAT+: Prometheus’ inflammatory bowel drug succeeds in two mid-stage trials
An investigative medicine from Prometheus Biosciences met its goals in a pair of Phase 2…
STAT+: Pharmalittle: Zantac lawsuits tossed over inadequate scientific evidence; Lilly tightens access to diabetes drug used for weight loss
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Opinion: Deferral of primary care signals a troubled future for Americans’ health
Americans may be returning to their pre-pandemic habits, but most have not returned to their…
.jpg)
Limits of ‘Fauci effect’: infectious disease applicants plummet, and hospitals are scrambling
Tulane University touted “the chance to train in a unique & wonderful city.” The University…
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Touted by celebrities, raved about by TikTok users and advertised by med spas, a new…
A new coalition aims to close AI’s credibility gap in medicine with testing and oversight
To read the medical literature, you might think AI is taking over medicine. It can…
STAT+: Zantac lawsuits are tossed out as judge lambasts lack of evidence showing links to cancer
Several big drugmakers — Sanofi, GSK, Pfizer and Boehringer Ingelheim — will not have to…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $805 million in 2021
During 2021, drugmakers substantially raised prices on seven widely used medicines without any new clinical…
Apple scores victory in dispute over heart monitoring technologies in Apple Watch
In a significant victory, Apple has successfully challenged patents at the center of a high-profile…
STAT+: France’s drug regulator is under investigation for its handling of a thyroid drug
France’s drug regulator is being investigated for issuing misleading information in connection with a thyroid…
STAT+: “This is not a cure”: Consensus begins to emerge on new Alzheimer’s drug
NEW YORK — A consensus may be emerging about how to prescribe the new Alzheimer’s…
STATUS List Spotlight: A Conversation with Otis Brawley
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. This February,…
STAT+: U.S. delays backing for patent waivers on Covid-19 therapies and diagnostics
The U.S. government will not support extending a Dec. 17 deadline for waiving intellectual property…
Opinion: Victims of domestic abuse should get the same top-notch concussion care as athletes
Two vastly different experiences — serving as a “guest coach” on the sidelines for a…
STAT+: Gossamer drug for lung hypertension achieves study goal but with subpar treatment effect
Gossamer Bio said Tuesday that its experimental drug for pulmonary arterial hypertension achieved the main…
STAT+: Pharmalittle: FDA fast tracks OTC version of Narcan; Express Scripts to keep Humira on its formulary but add biosimilars
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: Karuna Therapeutics replaces its CEO, suggesting takeover unlikely soon
Karuna Therapeutics said Tuesday that its CEO, Steve Paul, will be replaced by Bill Meury,…
Congress has its sights set too low on addiction, advocates charge
Judging by lawmakers’ words, addiction might be the most bipartisan topic in Washington. For years,…
Opinion: Pediatricians and parents on the brink: This is their March 2020
In March 2020, as the Covid-19 pandemic swept across the United States, the nation’s pediatric…
STAT+: ‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches
Two years after it accused Apple of copying its heart monitoring technology and putting it…
Psychedelic therapy is moving to the next frontier: workplace perk
Acupuncture and chiropractic care weren’t always the common fixtures of employer benefit plans they are…
STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination study
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy…
New concerns about a paper co-authored by Stanford president prompt journal to take a ‘closer look’
The journal Cell is opening its own review of research co-authored by Stanford University president…
STAT+: A year after petition, NIH reviews request to lower cancer drug’s cost by sidestepping patents
One year after being asked to widen access to a pricey cancer treatment by using…
Opinion: Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics
Congress is considering two measures that modernize tools the Food and Drug Administration uses to…
STAT+: Pharmalittle: J&J drops out of bidding for Horizon; FDA takes a harder line on fast-track approvals
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Carefully crafted digital approaches can improve youths’ mental health care
In the face of a national emergency in child and adolescent mental health, urgent measures…
An AI model to predict kidney damage, trained on data from veterans, works less well in women
The study was a page-turner: Researchers at Google showed that an artificial intelligence system could…
Before making unbiased pulse oximeters, researchers need a better way to measure skin tone
There’s a growing consensus among physicians and government regulators that pulse oximeters measure oxygen levels…
.jpg)
STAT+: The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor
Next year, UnitedHealth Group — one of the largest health care companies on the planet…
STAT+: Thirty Madison, looking to stand out in a crowded telehealth market, quietly plans expansion into sleep care
In the fight to command the growing market for telehealth, Thirty Madison is staking out…
Medical malpractice lawsuits, delayed by the pandemic, are hitting hospitals harder than expected
Carlos David Castro Rojas was a healthy 27-year-old engineering student when he fell off a…
STAT+: AAM’s Dan Leonard, president of generic drug lobby, ousted
The generic drug industry’s lobbying group, the Association for Accessible Medicines, fired its president Dan…
Image manipulation in science is suddenly in the news. But these cases are hardly rare
In 2004, Mike Rossner and Kenneth Yamada, two top editors at the Journal of Cell…
STAT+: Inside one startup’s quest to build proteins from scratch using artificial intelligence
A Somerville startup and an academic lab in Seattle say they have developed a way…
STAT+: Pharmalittle: Private equity moving to buy clinical trials firms; data provider limits media access to drug prices
And so, another working week will soon draw to a close. Not a moment too…
STAT+: An Anavex study spin job sullies an otherwise spectacular Alzheimer’s conference
Anavex Life Sciences said Thursday that its experimental treatment for Alzheimer’s disease slowed the rate…
Opinion: Breakthrough Therapies Act: Good idea, wrong solution
The Breakthrough Therapies Act, recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.)…
‘The hospital never supported the midwives’: As more birth centers open, their viability hinges on nearby hospitals
BEVERLY, Mass. — It was fitting, one activist said, that the sky was storming on…
Opinion: Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans
You are what you eat. Every year, new scientific discoveries make clear that food is…